147 related articles for article (PubMed ID: 2180614)
1. Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.
Hedman A; Alván G; Strandvik B; Arvidsson A
Clin Pharmacokinet; 1990 Feb; 18(2):168-75. PubMed ID: 2180614
[TBL] [Abstract][Full Text] [Related]
2. Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.
Hedman A; Adan-Abdi Y; Alvan G; Strandvik B; Arvidsson A
Clin Pharmacokinet; 1988 Jul; 15(1):57-65. PubMed ID: 3042246
[TBL] [Abstract][Full Text] [Related]
3. Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects.
Arvidsson A; Alván G; Strandvik B
Acta Paediatr Scand; 1983 Mar; 72(2):293-4. PubMed ID: 6837304
[No Abstract] [Full Text] [Related]
4. Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis.
Spino M; Chai RP; Isles AF; Balfe JW; Brown RG; Thiessen JJ; MacLeod SM
J Pediatr; 1985 Jul; 107(1):64-70. PubMed ID: 3891948
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man.
Prescott LF; Freestone S; McAuslane JA
Clin Sci (Lond); 1991 Feb; 80(2):167-76. PubMed ID: 1848170
[TBL] [Abstract][Full Text] [Related]
6. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
Wang JP; Unadkat JD; al-Habet SM; O'Sullivan TA; Williams-Warren J; Smith AL; Ramsey B
Clin Pharmacol Ther; 1993 Sep; 54(3):293-302. PubMed ID: 8375124
[TBL] [Abstract][Full Text] [Related]
7. Renal function and renotropic effects of secretin in cystic fibrosis.
Windstetter D; Schaefer F; Schärer K; Reiter K; Eife R; Harms HK; Bertele-Harms R; Fiedler F; Tsui LC; Reitmeir P; Horster M; Hadorn HB
Eur J Med Res; 1997 Oct; 2(10):431-6. PubMed ID: 9348270
[TBL] [Abstract][Full Text] [Related]
8. Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers.
Orlando R; Floreani M; Padrini R; Palatini P
Br J Clin Pharmacol; 1998 Dec; 46(6):605-9. PubMed ID: 9862251
[TBL] [Abstract][Full Text] [Related]
9. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B
J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of four methods for measuring glomerular filtration rate by inulin clearance in healthy individuals and patients with renal failure].
Hernández Ocampo J; Torres Rosales A; Rodríguez Castellanos F
Nefrologia; 2010; 30(3):324-30. PubMed ID: 20414326
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects.
Golper TA; Noonan HM; Elzinga L; Gilbert D; Brummett R; Anderson JL; Bennett WM
Clin Pharmacol Ther; 1988 May; 43(5):565-70. PubMed ID: 3365918
[TBL] [Abstract][Full Text] [Related]
12. Cefsulodin kinetics in renal impairment.
Gibson TP; Granneman GR; Kallal JE; Sennello LT
Clin Pharmacol Ther; 1982 May; 31(5):602-8. PubMed ID: 7075110
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.
Reed MD; Stern RC; Yamashita TS; Ackers I; Myers CM; Blumer JL
Antimicrob Agents Chemother; 1984 May; 25(5):579-81. PubMed ID: 6732226
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of cefsulodin in patients with renal impairment.
Gibson TP; Granneman GR; Kallal JE; Sennello LT
Rev Infect Dis; 1984; 6 Suppl 3():S689-97. PubMed ID: 6571338
[TBL] [Abstract][Full Text] [Related]
15. Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport?
Susanto M; Benet LZ
Pharm Res; 2002 Apr; 19(4):457-62. PubMed ID: 12033380
[TBL] [Abstract][Full Text] [Related]
16. Decreased renal clearance of sodium in cystic fibrosis.
Stenvinkel P; Hjelte L; Alván G; Hedman A; Hultman E; Strandvik B
Acta Paediatr Scand; 1991 Feb; 80(2):194-8. PubMed ID: 2035310
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
[TBL] [Abstract][Full Text] [Related]
18. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
Blonde L; Wehmann RE; Steiner AL
J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.
Prandota J
Drugs; 1988 May; 35(5):542-78. PubMed ID: 3293970
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of proinsulin, insulin, and C-peptide in the rat.
Katz AI; Rubenstein AH
J Clin Invest; 1973 May; 52(5):1113-21. PubMed ID: 4700486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
